Answers are grounded in this paper and cite their sources.
Background/Aims: Endoscopic submucosal dissection (ESD) may be associated with delayed adverse events (AEs), including bleeding and perforation. We aimed to synthesize the current evidence comparing defect closure with no closure after gastric ESD for the prevention of delayed bleeding. Methods: A comprehensive literature search was conducted to identify studies evaluating delayed AEs after gastric ESD. Pooled effect estimates were calculated. Results: Of 2,321 citations, eight studies comprising 2,729 patients were included. En bloc and R0 resection rates were comparable between the closure and no-closure groups (risk ratio [RR], 0.99; 95% confidence interval [CI], 0.98–1.01; I 2 =0% and RR, 1.03; 95% CI, 0.99–1.06; I 2 =47%, respectively). The risk of delayed bleeding was significantly lower in the closure group than in the no-closure group (RR, 0.38; 95% CI, 0.17–0.85; I 2 =65.9%). In studies limited to patients receiving antithrombotic therapy (ATT), the risk reduction was more pronounced (RR, 0.20; 95% CI, 0.06–0.66). No delayed perforation events were reported in either group. Conclusions: Considering the clinical and methodological heterogeneity and the predominantly observational nature of the included studies, this meta-analysis suggests that defect closure after gastric ESD may be associated with a reduced risk of delayed bleeding, particularly among patients receiving ATT.
No takes yet. Share an insight, caveat, or question.
Almasri et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: